In this disease, you will get some signs and symptoms. These are:
Genetic Disease Testing is the genetic testing of DNA and RNA to detect mutations that cause a risk of developing certain diseases. This type of testing is used to identify genetic disorders, determine paternity and to detect mutations that cause a risk of developing certain diseases.
Genetic testing is a laboratory analysis of DNA, RNA or chromosomes in order to diagnose or predict an inherited disease or condition such as cystic fibrosis (CF), breast cancer and Huntington's disease.
Oncology is one of the most important segments of Molecular Diagnostics market. Cancer is one of the most common diseases in the world, and there are many types of cancer that affect more than 12 million Americans every year. The cancerous cells grow abnormally and damage healthy tissues around them; they can also invade nearby organs.
In oncology molecular diagnostics, doctors use molecular diagnostic tests to help diagnose or monitor a disease such as cancer by looking for abnormalities in genes or proteins that have been altered by cancer cells. There are several types of molecular diagnostic tests including blood cell counts (CBCs), enzyme-linked immunosorbent assays (ELISAs), flow cytometry tests (FCTs), immunohistochemistry experiments (IHCs), polymerase chain reaction analyses (PCRAs) and western blotting techniques etc., which help physicians evaluate patients’ conditions based on their genetic makeup or other factors related to their bodies
Others (Pre-implantation Genetic Diagnosis, Pharmacogenetic Testing and Veterinary Molecular Diagnostics)
The global MDR market includes the following types of molecular diagnostics: pre-implantation genetic diagnosis (PGD), pharmacogenetic testing, veterinary molecular diagnostics, other types of molecular diagnostics.
The segmentation of Molecular Diagnostics market is done on the basis of application. The infectious disease, blood screening, genetic disease testing, oncology and others (pre-implantation genetic diagnosis, pharmacogenetic testing & veterinary molecular diagnostics) are some of the key segments in this industry.
Genetic disease testing includes tests that detect the presence of certain mutated genes responsible for various hereditary disorders such as HbS Thalassemia (Beta thalassemia trait) or Alport syndrome (alpha1-antitrypsin deficiency). Oncology Oncology refers to any form of cancer involving abnormal growths (tumors) within cells or tissues that form part of an organ system in your body like lungs etcetera.
The market is segmented into product and end user. The product segmentation includes instruments, reagents, consumables and services. While instruments are further sub-segmented into thermocyclers, hybridization systems, spectrometers, cell counters and others.
On the basis of product, the market is segmented into instruments, reagents, consumables and services.
Instruments are used for genetic analysis of diseased cells. These include DNA sequencers, gene analyzers and DNA microarrays. Reagents are used in various processes like hybridization systems and electrophoresis buffer to detect disease markers in a sample by detecting specific genes or proteins through fluorescent probes or antibodies attached to them respectively. Consumables can be further categorized as magnetic particles (dye-labeled nucleotides), nylon membranes (for dot blotting), nylon membrane filters for immunoassays; glass slides for Southern blotting; gels for electrophoresis etc. Services include training sessions on molecular diagnostics procedures along with software maintenance contracts which provide remote support to customers; technical support services such as installation/set up charges etc.; education on how to use equipment effectively; demonstrations on new technology updates etc.; post sales services like repair facility maintenance contracts at affordable prices if any part needs replacement due to malfunctioning after warranty period has expired
The instruments segment is sub-segmented into thermocyclers, hybridization systems, spectrometers, cell counters and others. The thermocyclers market is further classified into thermal cyclers and real-time PCR machines. Thermal cyclers are used for PCR amplification of DNA segments in a closed system under controlled temperature conditions while real-time PCR machines are able to perform both the functions of thermal cycling and detection of fluorescent signal during the amplification process simultaneously. This allows users to monitor the reaction kinetics during the course of amplification which helps in optimising quality parameters like specificity or sensitivity while running multiplex assays on multiple samples at once.
Reagents are further divided based on the type of molecular diagnostic test. The reagents used in Next-generation Sequencing (NGS) include DNA sequencing reagents, amplification reagents, label detection reagents and others. In addition to NGS, other types of molecular diagnostics include DGMx (Diagnostic Gene Microarray), PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay).
The market has been segmented based on end users into Hospitals & Clinics, Research Institutes/Laboratories and Diagnostic Centers & Labs.
The consumables segment is divided as plastic disposables, serological pipettes, tubes DNA purification kits and others.
a. Reagent pipettes for microarrays and droplet digital PCR (ddPCR).
b. Tubes for sample preparation including automated liquid handling (ALH) systems are used in various types of processes like DNA purification kits and others. The most commonly used tubes include blood collection tubes (BST), serum separator tube (SST), plasma separator tube (PST) and peripheral blood mononuclear cell collection tube (PBMC).
The services are sub-segmented into validation & testing, consulting & advisory services and others.
On the end user the market is divided into hospitals & diagnostic centers and research laboratories. The hospitals & diagnostic centers segment is expected to grow at a CAGR of around 9.5% during forecast period, owing to rising awareness about cancer treatment and increased government initiatives for developing healthcare infrastructure in emerging economies like India, China, Brazil etc.
Molecular diagnostics is a highly promising market with growing demand for personalized medicine. The market is segmented into product and end user. On the basis of product, the market is segmented into instruments, reagents, consumables and services. On the basis on end user, it has been segmented into hospitals and diagnostic centres (hospitals), ambulatory care centers (physicians' offices), research institutes & academic institutions and others (bio-pharmaceutical companies).
To sum up, the global Molecular Diagnostics market is expected to register a CAGR of 9.7% during the forecast period. The Infectious disease segment was estimated to account for around 60% share in 2017.